Keyphrases
Advanced Prostate Cancer
100%
PARP Inhibitor (PARPi)
100%
Inhibitor Treatment
100%
Clonal Hematopoiesis
100%
Acute Myeloid Leukemia
33%
Myelodysplastic Syndrome
33%
Working Diagnosis
22%
Blood Samples
22%
PPM1D
22%
Clinically Significant
11%
Leukocytes
11%
Prostate Cancer
11%
Precursor Lesions
11%
Prior Treatment
11%
Gleason Score 7
11%
Gleason
11%
Sequence Method
11%
Patients with Prostate Cancer
11%
Localized Disease
11%
Myeloid Malignancies
11%
DNMT3A
11%
Tet Methylcytosine Dioxygenase 2
11%
Ultra-deep Well
11%
Variant Allele Frequency
11%
Unique Molecular Identifiers
11%
Medicine and Dentistry
Prevalence
100%
Prostate Cancer
100%
PARP Inhibitor
100%
Hematopoiesis
100%
Acute Myeloid Leukemia
33%
Myelodysplastic Syndrome
33%
Disease
22%
Precursor
11%
Side Effect
11%
Leukocyte
11%
Gene Frequency
11%
Localized Disease
11%
Myeloid Malignancy
11%
DNA Methyltransferase 3A
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Prostate Cancer
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
100%
Disease
33%
Acute Myeloid Leukemia
33%
Myelodysplastic Syndrome
33%
Side Effect
11%
DNA Methyltransferase 3A
11%